anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

156,841-156,900 of 319,975

filter-aware
04
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
05
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a split-screen layout to contrast past performance with future outlook.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a structured table format to present segment-specific performance data and corporate financial highlights.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Satisfaction1 hit
08
Includes non-GAAP organic growth metrics; footnotes clarify definitions.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Satisfaction1 hit
09
Includes GAAP and non-GAAP financial measures with extensive footnotes regarding adjustments and methodology.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Satisfaction1 hit
10
Includes extensive footnotes regarding non-GAAP adjustments and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes detailed footnotes regarding non-GAAP adjustments and specific financial events.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
12
Includes detailed footnotes explaining debt adjustments and restricted cash.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
13
The slide uses a blue box to visually emphasize the years 2021-2023 having zero debt maturities.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
14
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
15
Includes detailed footnotes regarding non-GAAP adjustments and specific expense categories.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses two separate waterfall charts to illustrate the bridge between 2020 actuals and 2021 guidance.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
17
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Includes a bar chart showing quarterly organic growth from 1Q16 to 4Q20, highlighting a pre-COVID growth period and a post-COVID recovery.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
The slide uses a consistent visual language (blue dashed lines and arrows) to highlight 'Recovery in Progress' across different metrics.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
The slide uses a mix of simple bar charts for product growth and grouped bar charts for consumer segment growth.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a three-part structure to validate the product launch: market size, global reach, and customer satisfaction.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
22
Includes a visual callout for 'Strong Growth Pre-COVID' and 'Recovery in Progress'.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses trend lines to indicate recovery trajectories for three key pharmaceutical products.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
24
The slide also includes a specific callout regarding Trulance NRx market share growth from March 2019 to December 2020.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
25
Includes a bar chart showing quarterly organic growth trends and text summaries of product-specific performance.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
26
The slide uses a mix of bar charts for market share and line charts for prescription trends to demonstrate recovery.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
28
Includes a list of key growth drivers and a visual grid of brand logos.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
29
The slide uses a timeline-like structure to present upcoming clinical trial milestones and recent COVID-19 treatment developments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
30
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
31
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
32
The diagram shows a process flow starting from operational improvements (EBITDA, working capital, delever) leading to three distinct strategic paths.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
33
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
34
The slide uses specific financial growth targets to set expectations for the 2019-2022 period.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
35
The slide uses a list-based structure to track product development milestones and launch timelines.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
36
LOE = Loss of Exclusivity. Data points include revenue and profit figures for 5 business units plus an overall company total.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
The table tracks financial performance variances across six business segments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
38
LOE stands for Loss of Exclusivity. The table highlights the financial decline associated with these events.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
LOE = Loss of Exclusivity. Red text in product list indicates anticipated dates.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
40
The table tracks inventory changes across two periods (4Q19 and 4Q20) for four specific business units.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
41
The table tracks inventory levels for Bausch Health business units.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
42
The slide highlights a 0% organic revenue change for the segment.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
44
Includes non-GAAP metrics and organic growth calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
45
Includes a callout box highlighting a 6% growth in WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
46
Includes non-GAAP metrics and constant currency adjustments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
47
The slide includes a specific callout for the 6% organic revenue decline and provides context on product-level performance (XIFAXAN and APRISO).Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
48
Includes non-GAAP metrics like EBITA and organic growth; highlights LOE revenue drag.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
49
Includes specific commentary on product-level revenue drivers and LOE impacts.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
50
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
51
Includes footnotes regarding non-GAAP information and constant currency calculations.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
52
The table provides a comparative view of product performance over time.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
53
Bausch Health Companies | Results Presentation Deck | 82 slidesBausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
54
The table provides a comparative view of product performance over time.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
55
The table highlights FY20 and FY19 data in blue columns.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
56
Data represents U.S. only sales.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
57
The table provides a detailed breakdown of income/expense and earnings per share impact for both three-month and twelve-month periods ending December 31, 2020 and 2019.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
58
The table provides a detailed breakdown of financial metrics for the segment, including non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
59
Includes non-GAAP metrics and segment-specific P&L line items.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
60
Includes footnotes regarding F/X changes, non-GAAP information, and amortization/impairment details.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
61
The table includes non-GAAP financial measures and references an appendix for further details.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
62
The slide presents two separate tables for Q4 2020 and Q4 2019, detailing various expense adjustments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit
63
The slide presents two separate tables for YTD 2020 and YTD 2019, detailing various non-GAAP adjustments.Bausch Health Companies | Results Presentation Deck | 82 slides · Bausch Health
Conference presentation Investor relations 1 hit